0001382963-15-000139.txt : 20151124 0001382963-15-000139.hdr.sgml : 20151124 20151124155830 ACCESSION NUMBER: 0001382963-15-000139 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151124 DATE AS OF CHANGE: 20151124 EFFECTIVENESS DATE: 20151124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neurotrope, Inc. CENTRAL INDEX KEY: 0001513856 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463522381 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-251855 FILM NUMBER: 151252661 BUSINESS ADDRESS: STREET 1: 10732 HAWK?S VISTA STREET CITY: PLANTATION STATE: FL ZIP: 33324 BUSINESS PHONE: (945) 632-6630 MAIL ADDRESS: STREET 1: 10732 HAWK?S VISTA STREET CITY: PLANTATION STATE: FL ZIP: 33324 FORMER COMPANY: FORMER CONFORMED NAME: BlueFlash Communications, Inc. DATE OF NAME CHANGE: 20110223 D 1 primary_doc.xml X0707 D LIVE 0001513856 Neurotrope, Inc. 50 Park Place 14th Floor Newark NJ NEW JERSEY 07102 (973) 242-0005 NEVADA BlueFlash Communications, Inc. Corporation true 2013 Charles S. Ramat 50 Park Place 14th Floor Newark NJ NEW JERSEY 07102 Executive Officer Director Robert Weinstein 50 Park Place 14th Floor Newark NJ NEW JERSEY 07102 Executive Officer Paul E. Freiman 50 Park Place 14th Floor Newark NJ NEW JERSEY 07102 Director Chairman of the Board William Singer 50 Park Place 14th Floor Newark NJ NEW JERSEY 07102 Director Vice Chairman of the Board James Gottlieb 50 Park Place 14th Floor Newark NJ NEW JERSEY 07102 Director Jay M. Haft 50 Park Place 14th Floor Newark NJ NEW JERSEY 07102 Director Larry D. Altstiel, MD 50 Park Place 14th Floor Newark NJ NEW JERSEY 07102 Director Biotechnology Decline to Disclose 06b false 2015-11-13 false true true true false 0 Katalyst Securities LLC 112494 None None 15 Maiden Lane Room 601 New York NY NEW YORK 10038 AL ALABAMA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA ID IDAHO IL ILLINOIS IN INDIANA IA IOWA KS KANSAS KY KENTUCKY LA LOUISIANA ME MAINE MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI NV NEVADA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA ND NORTH DAKOTA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA TX TEXAS UT UTAH VT VERMONT VA VIRGINIA WA WASHINGTON WV WEST VIRGINIA WI WISCONSIN false 20000000 15329920 4670080 false 136 1532992 true 0 In addition to a cash fee, Katalyst Securities will receive warrants to purchase common stock of the Issuer. These warrants will be issued in the amounts and on terms as described in the Issuer's Form 8-K as filed with the SEC on November 19, 2015. 0 Mr. Ramat, identified in Item 3 as a Related Person, is entitled to receive a stock option exercisable for 100,000 shares of the common stock of the Issuer. false Neurotrope, Inc. /s/ Robert Weinstein Robert Weinstein Chief Financial Officer 2015-11-24